The GABAB receptor mediates neuroprotection by coupling to G13
Yunyun Wang1, Siyu Gai1, Wenhua Zhang1
1Cellular Signaling laboratory, International Research Center for Sensory Biology and Technology of MOST, Key Laboratory of Molecular Biophysics of MOE, School of Life Science and Technology, Huazhong University of Science and Technology, 430074 Wuhan, China.
Abstract:
G protein–coupled receptors (GPCRs) activate various mitogen-activated protein kinase (MAPK) pathways to regulate critical cell functions. β-Arrestins mediate this mechanism for most GPCRs but not the GABAB receptor (GABABR). When coupled to the G protein Gi/o, GABABR phosphorylates the kinases ERK1 and ERK2. Here, we uncovered a distinct β-arrestin–independent mechanism of MAPK pathway activation by GABABR. We found that GABABR also phosphorylated the kinase JNK downstream of activation of the small guanosine triphosphatases (GTPases) RhoA and Rac1 in primary mouse neurons. However, instead of Gi/o proteins, activation of this RhoA/Rac1-JNK pathway was mediated by G13. This pathway promoted the phosphorylation and accumulation of the postsynaptic scaffolding protein PSD95 and GABABR-mediated neuroprotection in granule neurons. In addition, this pathway synergized with a previously reported GABABR-mediated neuroprotection mediated by a Gi/o-dependent mechanism. GABABR agonists activated G13 with slower kinetics and lower potency than with which they activated Gi/o. Our findings reveal distinct, β-arrestin–independent, context-specific synergistic mechanisms of MAPK activation by G protein–mediated GPCR signaling.
Insights
GABAB receptors activate MAPK pathways independently of β-arrestins. A novel G13-mediated pathway involving RhoA/Rac1 and JNK promotes neuroprotection, working alongside a known Gi/o pathway.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- G protein–coupled receptors (GPCRs) regulate cell functions via mitogen-activated protein kinase (MAPK) pathways.
- β-Arrestins typically mediate GPCR-MAPK signaling, but not for the GABAB receptor (GABABR).
- GABABR, when coupled to Gi/o, activates ERK1/2 kinases.
Purpose of the Study:
- To uncover a distinct β-arrestin–independent mechanism of MAPK pathway activation by GABABR.
- To elucidate the role of G13 in GABABR-mediated signaling.
- To investigate the contribution of this novel pathway to neuroprotection.
Main Methods:
- Utilized primary mouse neurons to study GABABR signaling.
- Investigated the activation of small guanosine triphosphatases (GTPases) RhoA and Rac1.
- Assessed the phosphorylation and accumulation of PSD95 and GABABR-mediated neuroprotection.
Main Results:
- Discovered a β-arrestin–independent pathway where GABABR activates JNK via G13, RhoA, and Rac1.
- This pathway promotes PSD95 phosphorylation and accumulation, contributing to neuroprotection.
- The G13-JNK pathway synergizes with the known Gi/o-ERK pathway for enhanced neuroprotection.
- G13 activation by GABABR agonists shows slower kinetics and lower potency compared to Gi/o activation.
Conclusions:
- GABABR employs distinct, β-arrestin–independent mechanisms for MAPK activation.
- G13-mediated signaling represents a novel pathway for GABABR function.
- These synergistic pathways contribute to GABABR-mediated neuroprotection in a context-specific manner.
Related Concept Videos
GPCR Desensitization
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
G-Protein Gated Ion Channels
Sensory...
G-protein Coupled Receptors
Activation and Inactivation of G Proteins


